Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:KURO
- CUSIP: N/A
- Web: N/A
- Market Cap: $174.1 million
- Outstanding Shares: 14,508,000
- 50 Day Moving Avg: $12.00
- 200 Day Moving Avg: $12.00
- 52 Week Range: $12.00 - $12.00
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -4.80
- P/E Growth: 0.00
- Annual Revenue: N/A
- Price / Sales: N/A
- Book Value: $4.08 per share
- Price / Book: 2.94
Frequently Asked Questions for Kura Oncology (NASDAQ:KURO)
What is Kura Oncology's stock symbol?
Kura Oncology trades on the NASDAQ under the ticker symbol "KURO."
Who are some of Kura Oncology's key competitors?
Some companies that are related to Kura Oncology include Landec Corporation (LNDC), NewLink Genetics Corporation (NLNK), Primo Water Corporation (PRMW), Fogo de Chao (FOGO), TICC Capital Corp. (TICC), Old Line Bancshares (OLBK), Pharming Group (PHGUF), Kura Oncology (KURA), Internap Corporation (INAP), ViewRay (VRAY), Artesian Resources Corporation (ARTNA), Marlin Business Services Corp. (MRLN), Hawaiian Telcom Holdco (HCOM), Rockwell Medical (RMTI), AXT (AXTI), Concert Pharmaceuticals (CNCE), RA PHARMCTL INC (RARX) and Superior Uniform Group (SGC).
Who owns Kura Oncology stock?
Kura Oncology's stock is owned by a number of of retail and institutional investors. Top institutional investors include
ECOR1 CAPITAL, LLC
GREAT POINT PARTNERS LLC
(5.92%). View Institutional Ownership Trends for Kura Oncology.
How do I buy Kura Oncology stock?
Shares of Kura Oncology can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Kura Oncology's stock price today?
MarketBeat Community Rating for Kura Oncology (NASDAQ KURO)MarketBeat's community ratings are surveys of what our community members think about Kura Oncology and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Kura Oncology stock can currently be purchased for approximately $12.00.
Consensus Ratings for Kura Oncology (NASDAQ:KURO) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Kura Oncology (NASDAQ:KURO)
(Data available from 9/21/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|12/30/2015||Oppenheimer Holdings, Inc.||Initiated Coverage||Outperform||N/A|
Earnings History for Kura Oncology (NASDAQ:KURO)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Kura Oncology (NASDAQ:KURO)
Current Year EPS Consensus Estimate: $-2.58 EPS
Next Year EPS Consensus Estimate: $-2.50 EPS
Dividend History for Kura Oncology (NASDAQ:KURO)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Kura Oncology (NASDAQ:KURO)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Kura Oncology (NASDAQ:KURO)
Latest Headlines for Kura Oncology (NASDAQ:KURO)
Kura Oncology (KURO) Chart for Thursday, September, 21, 2017